Abstract
Background: This paper tries to demonstrate that the questionnaire-based continuum between temperament traits and psychopathology can also be shown on the biochemical level. A common feature is the incapacity to adapt to external demands, as demonstrated by examples of disturbed hormone cycles as well as neurotransmitter (TM) responses related to affective and impulse control disorders. Methods: Pharmacological challenge tests performed in placebo-controlled balanced crossover experiments with consecutive challenges by serotonin (5-HT), noradrenaline (NA), and dopamine (DA) agonistic drugs were applied to healthy subjects, and individual responsivities of each TM system assessed by respective cortisol and prolactin responses were related to questionnaire-based facets of depressiveness and impulsivity, respectively. Results: The depression-related traits “Fatigue” and “Physical Anhedonia” were characterized by low and late responses to DA stimulation as opposed to “Social Anhedonia,” which rather mirrored the pattern of schizophrenia. Reward-related and premature responding-related impulsivity represented by high scores on “Disinhibition” and “Motor Impulsivity,” respectively, as well as the questionnaire-based components of attention deficit hyperactivity disorder, “Cognitive” and “Motor Impulsivity,” could be discriminated by their patterns of DA/NA responses. 5-HT responses suggested that instead of the expected low availability of 5-HT claimed to be associated with impulse control disorders, low NA responses indicated lack of inhibition in impulsivity and high NA responses in depression-related “Anhedonia” indicated suppression of approach motivation. Conclusions: In spite of the flaws of pharmacological challenge tests, they may be suitable for demonstrating similarities in TM affinities between psychopathological disturbances and respective temperament traits and for separating sub-entities of larger disease spectra.
References
1.
Kretschmer
E
. Körperbau und Charakter [Body build and character]
. Berlin: Springer
; 1921
.2.
3.
Cloninger
CR
. A unified biosocial theory of personality and its role in the development of anxiety states
. Psychiatr Dev
. 1986
;4
(3
):167
–226
.4.
Depue
RA
, Lenzenweger
MF
, Clarkin
JF
. Major theories of personality disorder
. New York
: Guilford Press
; 2005
.5.
Trofimova
I
, Robbins
TW
. Temperament and arousal systems: a new synthesis of differential psychology and functional neurochemistry
. Neurosci Biobehav Rev
. 2016
;64
:382
–402
. .6.
Sulis
W
. Assessing the continuum between temperament and affective illness: psychiatric and mathematical perspectives
. Phil Trans R Soc B
. 2018
;373
(1744
):20170168
. .7.
Netter
P
. Benefits and limitations of drug studies in temperament research: biochemical responses as indicators of temperament
. Phil Trans R Soc B
. 2018
;373
(1744
):20170165
. .8.
American Psychiatric Association
. Diagnostisches und statistisches Manual psychischer Störungen–DSM-5. Hogrefe Verlag (Original 8 erased)
, 2014
.9.
Brandes
CM
, Tackett
JL
. Contextualizing neuroticism in the hierarchical taxonomy of psychopathology
. J Res Pers
. 2019
;81
:238
–45
. .10.
Strelau
J
, Zawadzki
B
. The formal characteristics of behaviour: temperament inventory (FCB—TI): validity studies
. Eur J Pers
. 1995
;9
(3
):207
–29
.11.
Rusalov
V
. Functional systems theory and the activity-specific approach in psychological taxonomies
. Phil Trans R Soc B
. 2018
;373
(1744
):20170166
. .12.
Trofimova I
. The interlocking between functional aspects of activities and a neurochemical model of adult temperament
. Temperaments: individual differences, social and environmental influences and impact on quality of life
. 2016
. p. 77
–147
.13.
Selye
H
. The general adaptation syndrome and the diseases of adaptation
. J Clin Endocrinol Metab
. 1946
;6
(2
):117
–230
. .14.
Trofimova
I
. Functionality versus dimensionality in psychological taxonomies, and a puzzle of emotional valence
. Phil Trans R Soc B
. 2018
;373
(1744
):20170167
. .15.
Rusalov
V
, Trofimova
I
. Structure of temperament and its measurement
. Psychological Services Press
; 2007
.16.
Haynes
SN
, Gannon
LR
, Orimoto
L
, O’Brien
WH
, Brandt
M
, et al. Psychophysiological assessment of poststress recovery
. Psychol Assess
. 1991
;3
(3
):356
. .17.
Williams
PG
, Smith
TW
, Gunn
HE
, Uchino
BN
. Personality and stress: Individual differences in exposure, reactivity, recovery, and restoration
. The handbook of stress science: biology, psychology, and health
. 2011
. p. 231
–45
.18.
Vogel
WH
, Netter
P
. Effect of ethanol and stress on plasma catecholamines and their relation to changes in emotional state and performance
. Alcohol Clin Exp Res
. 1989
;13
(2
):284
–90
. .19.
Netter
P
. Psychological aspects of catecholamine response patterns to pain and mental stress in essential hypertensive patients and controls
. J Clin Hypertens
. 1987
;3
(4
):727
–42
.20.
Netter
P
, Lienert
GA
. Response curve analysis of catecholamine release under social stress
. Studia Psychologica
. 1984
;26
(3
):179
.21.
Swenson
RM
, Vogel
WH
. Plasma catecholamine and corticosterone as well as brain catecholamine changes during coping in rats exposed to stressful footshock
. Pharmacol Biochem Behav
. 1983
;18
(5
):689
–93
. .22.
Boudarene
M
, Legros
JJ
, Timsit-Berthier
M
. Study of the stress response: role of anxiety, cortisol and DHEAs
. L’Encephale
. 2002
;28
(2
):139
.23.
Croes
S
, Merz
P
, Netter
P
. Cortisol reaction in success and failure condition in endogenous depressed patients and controls
. Psychoneuroendocrinology
. 1993
;18
(1
):23
–35
. .24.
Grossi
G
, Åhs
A
, Lundberg
U
. Psychological correlates of salivary cortisol secretion among unemployed men and women
. Integr Physiol Behav Sci
. 1998
;33
(3
):249
–63
. .25.
Conrad
N
. Cortisol, affective states and performance in a condition of mental stress in unipolar depressed and healthy smokers and non-smokers
. MD thesis
, Medical Faculty University of Giessen
, 2001
.26.
Shull
A
, Mayer
SE
, McGinnis
E
, Geiss
E
, Vargas
I
, Lopez-Duran
NL
. Trait and state rumination interact to prolong cortisol activation to psychosocial stress in females
. Psychoneuroendocrinology
. 2016
;74
:324
–32
. .27.
Kirschbaum
C
, Prüssner
JC
, Stone
AA
, Federenko
I
, Gaab
J
, Lintz
D
, et al. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men
. Psychosom Med
. 1995
;57
(5
):468
–74
. .28.
Abreu
T
, Bragança
M
. The bipolarity of light and dark: a review on bipolar disorder and circadian cycles
. J Affect Disord
. 2015
;185
:219
–29
. .29.
Melo
MCA
, Abreu
RLC
, Linhares Neto
VB
, de Bruin
PFC
, de Bruin
VMS
. Chronotype and circadian rhythm in bipolar disorder: a systematic review
. Sleep Med Rev
. 2017
;34
:46
–58
. .30.
Copinschi
G
, Spiegel
K
, Leproult
R
, Van Cauter
E
. Pathophysiology of human circadian rhythms
. In: Mechanisms and biological significance of pulsatile hormone secretion: Novartis Foundation Symposium 227
. Chichester, UK
: John Wiley & Sons, Ltd
; 2000 Jan
. Vol. 227
; p. 143
–62
.31.
Grandin
LD
, Alloy
LB
, Abramson
LY
. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation
. Clin Psychol Rev
. 2006
;26
(6
):679
–94
. .32.
Van Someren
EJW
. Circadian and sleep disturbances in the elderly
. Exp Gerontol
. 2000
;35
(9–10
):1229
–37
. .33.
Germain
A
, Kupfer
DJ
. Circadian rhythm disturbances in depression
. Hum Psychopharmacol
. 2008
;23
(7
):571
–85
. .34.
Mauri
M
. Sleep and the reproductive cycle: a review
. Health Care Women Int
. 1990
;11
(4
):409
–21
. .35.
Netter
P
, Hennig
J
, Huwe
S
, Daume
E
. Disturbed behavioural adaptability as related to reproductive hormones and emotional states during the menstrual cycle
. Eur J Pers
. 1998
;12
(4
):287
–300
. .36.
Fahrenberg
J
, Hampel
R
, Selg
H
. Das Freiburger Persönlichkeitsinventar: rev. Fassung FPI-R u. teilw. geänd. Fassung FPI-A1. Hogrefe
. 1984
.37.
Garcia-Banda
G
, Chellew
K
, Fornes
J
, Perez
G
, Servera
M
, Evans
P
. Neuroticism and cortisol: pinning down an expected effect
. Int J Psychophysiol
. 2014
;91
(2
):132
–8
. .38.
Haus
E
, Smolensky
M
. Biological clocks and shift work: circadian dysregulation and potential long-term effects
. Cancer Causes Control
. 2006
;17
(4
):489
–500
. .39.
Mahoney
MM
. Shift work, jet lag, and female reproduction
. Int J Endocrinol
. 2010
;2010
:813764
.40.
Fujiwara
S
, Shinkai
S
, Kurokawa
Y
, Watanabe
T
. The acute effects of experimental short-term evening and night shifts on human circadian rhythm: the oral temperature, heart rate, serum cortisol and urinary catecholamines levels
. Int Arch Occup Environ Health
. 1992
;63
(6
):409
–18
. .41.
Hennig
J
, Kieferdorf
P
, Moritz
C
, Huwe
S
, Netter
P
. Changes in cortisol secretion during shiftwork: implications for tolerance to shiftwork?
Ergonomics
. 1998
;41
(5
):610
–21
. .42.
Netter
. Personality and hormones in RM Stelmack: on the psychobiology of personality
. Amsterdamn
: Elsevier
; 2004
. p. 334
–7
.43.
Fahn
S
, Libsch
LR
, Cutler
RW
. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson’s disease and their role in akinesia, rigidity, chorea, and tremor
. J Neurol Sci
. 1971
;14
(4
):427
–55
.44.
Kaasinen
V
, Nurmi
E
, Bergman
J
, Eskola
O
, Solin
O
, Sonninen
P
, et al. Personality traits and brain dopaminergic function in Parkinson’s disease
. Proc Natl Acad Sci U S A
. 2001
;98
(23
):13272
–7
. .45.
Denys
D
, Zohar
J
, Westenberg
HG
. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence
. J Clin Psychiatry
. 2004
;65
(Suppl 14
):11
.46.
Cools
R
, Frank
MJ
, Gibbs
SE
, Miyakawa
A
, Jagust
W
, D’Esposito
M
. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration
. J Neurosci
. 2009
;29
(5
):1538
–43
. .47.
Haluk
DM
, Floresco
SB
. Ventral striatal dopamine modulation of different forms of behavioral flexibility
. Neuropsychopharmacology
. 2009
;34
(8
):2041
–52
. .48.
Ouden
HE
, Daw
ND
, Fernandez
G
, Elshout
JA
, Rijpkema
M
, Hoogman
M
, et al. Dissociable effects of dopamine and serotonin on reversal learning
. Neuron
. 2013
;80
(4
):1090
–100
.49.
Beeler
JA
, Cools
R
, Luciana
M
, Ostlund
SB
, Petzinger
G
. A kinder, gentler dopamine… highlighting dopamine’s role in behavioral flexibility highlighting dopamine’s role in behavioral flexibility
. Front Neurosci
. 2014
;8
:4
. .50.
Mehta
MA
, Manes
FF
, Magnolfi
G
, Sahakian
BJ
, Robbins
TW
. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers
. Psychopharmacology
. 2004
;176
(3–4
):331
–42
. .51.
Grace
AA
, Floresco
SB
, Goto
Y
, Lodge
DJ
. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
. Trends Neurosci
. 2007
;30
(5
):220
–7
. .52.
Pignatelli
M
, Bonci
A
. Role of dopamine neurons in reward and aversion: a synaptic plasticity perspective
. Neuron
. 2015
;86
(5
):1145
–57
. .53.
Dreher
JC
, Burnod
Y
. An integrative theory of the phasic and tonic modes of dopamine modulation in the prefrontal cortex
. Neural Netw
. 2002
;15
(4–6
):583
–602
. .54.
van Holstein
M
, Aarts
E
, van der Schaaf
ME
, Geurts
DE
, Verkes
RJ
, Franke
B
, et al. Human cognitive flexibility depends on dopamine D2 receptor signaling
. Psychopharmacology
. 2011
;218
(3
):567
–78
. .55.
Monte-Silva
K
, Kuo
MF
, Thirugnanasambandam
N
, Liebetanz
D
, Paulus
W
, Nitsche
MA
. Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans
. J Neurosci
. 2009
;29
(19
):6124
–31
. .56.
Colzato
LS
, Waszak
F
, Nieuwenhuis
S
, Posthuma
D
, Hommel
B
. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching
. Neuropsychologia
. 2010
;48
(9
):2764
–8
. .57.
Izquierdo
A
, Belcher
AM
, Scott
L
, Cazares
VA
, Chen
J
, O’dell
SJ
, et al. Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine
. Neuropsychopharmacology
. 2010
;35
(2
):505
–14
. .58.
Floresco
SB
. Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions
. Front Neurosci
. 2013
;7
:6
.59.
60.
Chapman
LJ
, Chapman
JP
, Raulin
ML
. Scales for physical and social anhedonia
. J Abnorm Psychol
. 1976
;85
(4
):374
. .61.
Cloninger
CR
, Przybeck
TR
, Svrakic
DM
, Wetzel
RD
. The Temperament and Character Inventory (TCI): a guide to its development and use
.62.
Tellegen
A
, Waller
NG
. Exploring personality through test construction: development of the multidimensional personality questionnaire
. The SAGE handbook of personality theory and assessment
. 2008
. Vol. 2
; p. 261
–92
.63.
Christensen
NJ
, Vestergaard
P
, Sørensen
T
, Rafaelsen
OJ
. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients
. Acta Psych Scand
. 1980
;61
(2
):178
–82
. .64.
Schildkraut
JJ
. The catecholamine hypothesis of affective disorders: a review of supporting evidence
. Am J Psychiatry
. 1965
;122
(5
):509
–22
. .65.
Hennig
J
, Lange
N
, Haag
A
, Rohrmann
S
, Netter
P
. Reboxetine in a neuroendocrine challenge paradigm: evidence for high cortisol responses in healthy volunteers scoring high on subclinical depression
. Int J Neuropsychopharmacol
. 2000
;3
(3
):193
–201
. .66.
Schüle
C
, Baghai
TC
, Eser
D
, Zwanzger
P
, Jordan
M
, Buechs
R
, et al. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients
. Psychopharmacology
. 2006
;186
(4
):601
. .67.
Leonard
BE
. The role of noradrenaline in depression: a review
. J Psychopharmacol
. 1997
;11
(Suppl 4
):S39
–47
.68.
Brunello
N
, Mendlewicz
J
, Kasper
S
, Leonard
B
, Montgomery
S
, Nelson
JC
, et al. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression
. Eur Neuropsychopharmacol
. 2002
;12
(5
):461
–75
. .69.
Netter
P
, Hennig
J
. Discriminating depression, physical and social anhedonia by neurotransmitter related challenge tests
. Psychology
. 2016
;7
(3
):275
–85
. .70.
Netter
P
, Hennig
J
. Responses to neurotransmitter related drugs in nicotine deprived smokers
. Pers Individ Differ
. 2017
;118
:77
–83
. .71.
Cools
AR
, Tuinstra
T
. Neurochemical evidence that mesolimbic noradrenaline directs mesolimbic dopamine, implying that noradrenaline, like dopamine, plays a key role in goal-directed and motivational behavior
. In: The Basal Ganglia VI
. Boston, MA
: Springer
; 2002
. p. 323
–33
.72.
Jasmin
L
, Narasaiah
M
, Tien
D
. Noradrenaline is necessary for the hedonic properties of addictive drugs
. Vasc Pharmacol
. 2006
;45
(4
):243
–50
. .73.
Ventura
R
, Cabib
S
, Alcaro
A
, Orsini
C
, Puglisi-Allegra
S
. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release
. J Neurosci
. 2003
;23
(5
):1879
–85
. .74.
Siever
LJ
, Uhde
TW
, Silberman
EK
, Jimerson
DC
, Aloi
JA
, Post
RM
, et al. Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls
. Psychiatry Res
. 1982
;6
(2
):171
. .75.
Ansseau
M
, Von Frenckell
R
, Cerfontaine
JL
, Papart
P
, Franck
G
, Timsit-Berthier
M
, et al. Blunted response of growth hormone to clonidine and apomorphine in endogenous depression
. Br J Psychiatry
. 1988
;153
(1
):65
–71
. .76.
Amsterdam
JD
, Maislin
G
, Skolnick
B
, Berwish
N
, Winokur
A
. Multiple hormone responses to clonidine administration in depressed patients and healthy volunteers
. Biol Psychiatry
. 1989
;26
(3
):265
–78
. .77.
Heuser
I
, Yassouridis
A
, Holsboer
F
. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders
. J Psychiatr Res
. 1994
;28
(4
):341
–56
. .78.
Modell
S
, Yassouridis
A
, Huber
J
, Holsboer
F
. Corticosteroid receptor function is decreased in depressed patients
. Neuroendocrinology
. 1997
;65
(3
):216
–22
. .79.
Ising
M
, Künzel
HE
, Binder
EB
, Nickel
T
, Modell
S
, Holsboer
F
. The combined dexamethasone/CRH test as a potential surrogate marker in depression
. Prog Neuropsychopharmacol Biol Psychiatry
. 2005
;29
(6
):1085
–93
. .80.
Carr
GV
, Lucki
I
. The role of serotonin receptor subtypes in treating depression: a review of animal studies
. Psychopharmacology
. 2011
;213
(2–3
):265
–87
. .81.
Brown
GW
, Harris
TO
. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene–environment interaction
. J Affect Disord
. 2008
;111
(1
):1
–12
.82.
Trofimova
IN
, Sulis
W
. A study of the coupling of FET temperament traits with major depression
. Front Psychol
. 2016
;7
:1848
. .83.
Newman
ME
, Shapira
B
, Lerer
B
. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review
. Int J Neuropsychopharmacol
. 1998
;1
(1
):49
–69
. .84.
Wolf
C
, Linden
DEJ
. Biological pathways to adaptability–interactions between genome, epigenome, nervous system and environment for adaptive behavior
. Genes Brain Behav
. 2012
;11
(1
):3
–28
. .85.
O’Keane
V
, Moloney
E
, O’Neill
H
, O’Connor
A
, Smith
C
, Dinan
TG
. Blunted prolactin responses to d-fenfluramine in sociopathy
. Br J Psychiatry
. 1992
;160
(5
):643
–6
.86.
Cleare
AJ
, Bond
AJ
. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects
. Psychiatry Res
. 1997
;69
(2–3
):89
–95
. .87.
Hennig
J
, Toll
C
, Schonlau
P
, Rohrmann
S
, Netter
P
. Endocrine responses after d-Fenfluramine and Ipsapirone challenge: further support for Cloninger’s tridimensional model of personality
. Neuropsychobiology
. 2000
;41
(1
):38
–47
.88.
Nautiyal
KM
, Hen
R
. Serotonin receptors in depression: from A to B
. F1000Res
. 2017
;6
:123
. .89.
Deakin
JFW
. A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
. J Psychopharmacol
. 1993
;7
(3
):283
–9
. .90.
Pitchot
W
, Reggers
J
, Pinto
E
, Hansenne
M
, Fuchs
S
, Pirard
S
, et al. Reduced dopaminergic activity in depressed suicides
. Psychoneuroendocrinology
. 2001
;26
(3
):331
–5
. .91.
Willner
P
, Golembiowska
K
, Klimek
V
, Muscat
R
. Changes in mesolimbic dopamine may explain stress-induced anhedonia
. Psychobiology
. 1991
;19
(1
):79
–84
.92.
Willner
P
, Hale
AS
, Argyropoulos
S
. Dopaminergic mechanism of antidepressant action in depressed patients
. J Affect Disord
. 2005
;86
(1
):37
–45
. .93.
Pitchot
W
, Moreno
AG
, Ansseau
M
, Von Frenckell
R
. Growth hormone response to apomorphine test in retarded vs agitated depressed patients
. Clin Neuropharmacol
. 1992
;15
:284B
. .94.
Rammsayer
TH
, Vogel
WH
. AMPT partially reverses euphoric but not psychomotor effects of alcohol in humans
. Psychobiology
. 1995
;23
(3
):248
–55
.95.
Fibiger
HC
. The dopamine hypotheses of schizophrenia and mood disorders: contradictions and speculations
. In: Willner
P
, Scheel-Kruger
J
, editors. The meso-limbic dopamine system: from motivation to action
. Chichester
: Wiley
; 1991
. p. 616
–63
.96.
Gunne
LM
, Anggard
E
, Jonsson
LE
. Clinical trials with amphetamine-blocking drugs
. Psychiatr Neurol Neurochir
. 1972
;75
:225
–6
.97.
Shah
PJ
, Ogilvie
AD
, Goodwin
GM
, Ebmeier
KP
. Clinical and psychometric correlates of dopamine D-2 binding in depression
. Psychol Med
. 1997
;27
:1247
–56
. .98.
Koob
GF
. Dopamine, addiction and reward
. In: Seminars in neuroscience
. Academic Press
. Vol. 4
; p. 139
–48
.99.
Dunlop
BW
, Nemeroff
CB
. The role of dopamine in the pathophysiology of depression
. Arch Gen Psychiatry
. 2007
;64
(3
):327
–37
. .100.
Dailly
E
, Chenu
F
, Renard
CE
, Bourin
M
. Dopamine, depression and antidepressants
. Fundam Clin Pharmacol
. 2004
;18
(6
):601
–7
. .101.
Netter
P
, Reuter
M
, Hennig
J
. Time of onset of hormone responses to challenge tests, a better marker for personality than size of responses?
J Physiol
. 2004
;18
:241
.102.
Netter
P
. Dopamine challenge tests as an indicator of psychological traits
. Human Psychopharmacol
. 2006
;21
(2
):91
–9
. .103.
Laakso
A
, Wallius
E
, Kajander
J
, Bergman
J
, Eskola
O
, Solin
O
, et al. Personality traits and striatal dopamine synthesis capacity in healthy subjects
. Am J Psychiatry
. 2003
;160
(5
):904
–10
. .104.
Nordström
AL
, Farde
L
, Halldin
C
. Time course of D 2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol
. Psychopharmacology
. 1992
;106
(4
):433
–8
. .105.
Ventura
R
, Morrone
C
, Puglisi-Allegra
S
. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward-and aversion-related stimuli
. Proc Natl Acad Sci U S A
. 2007
;104
(12
):5181
–6
. .106.
Puglisi-Allegra
S
, Ventura
R
. Prefrontal/accumbal catecholamine system processes emotionally driven attribution of motivational salience
. Rev Neurosci
. 2012
;23
(5–6
):509
–26
. .107.
Dalley
JW
, Roiser
JP
. Dopamine, serotonin and impulsivity
. Neuroscience
. 2012
;215
:42
–58
. .108.
Dalley
JW
, Robbins
TW
. Fractionating impulsivity: neuropsychiatric implications
. Nat Rev Neurosci
. 2017
;18
(3
):158
. .109.
Mar
AC
, Robbins
TW
. Delay discounting and impulsive choice in the rat
. Curr Protoc Neurosci
. 2007
;39
(1
):8
–22
. .110.
Åsberg
M
, Träskman
L
, Thorén
P
. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor?
Arch Gen Psychiatry
. 1976
;33
(10
):1193
–7
.111.
Brown
GL
, Goodwin
FK
, Ballenger
JC
, Goyer
PF
, Major
LF
. Aggression in humans correlates with cerebrospinal fluid amine metabolites
. Psychiatry Res
. 1979
;1
(2
):131
–9
. .112.
Krakowski
M
. Violence and serotonin: influence of impulse control, affect regulation, and social functioning
. J Neuropsychiatry Clin Neurosci
. 2003
;15
(3
):294
–305
. .113.
Coccaro
EF
. Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship
. Int Clin Psychopharmacol
. 1992
;7
(1
):3
–12
.114.
Seo
D
, Patrick
CJ
, Kennealy
PJ
. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders
. Aggress Violent Behav
. 2008
;13
(5
):383
. .115.
Pattij
T
, Schoffelmeer
AN
. Serotonin and inhibitory response control: focusing on the role of 5-HT1A receptors
. Eur J Pharmacol
. 2015
;753
:140
–5
.116.
Liu
YP
, Wilkinson
LS
, Robbins
TW
. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex
. Psychopharmacology
. 2004
;173
(1–2
):175
–85
. .117.
Winstanley
CA
, Theobald
DE
, Dalley
JW
, Robbins
TW
. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders
. Neuropsychopharmacology
. 2005
;30
(4
):669
–82
. .118.
Marsh
DM
, Dougherty
FG
, Moeller
AC
, Swann
R
. Spiga Laboratory-measured aggressive behavior of women: acute tryptophan depletion and augmentation
. Neuropsychopharmacology
. 2002
;26
(5
):660
–71
.119.
Winstanley
CA
, Dalley
JW
, Theobald
DE
, Robbins
TW
. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior
. Neuropsychopharmacology
. 2004
;29
(7
):1331
–43
. .120.
Zapf
, Stadler
C
, Demisch
L
, Schmitt
M
, Landgraf
M
, Poustka
F
. Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion
. Hum Psychopharmacol
. 2008
;23
(1
):43
–51
.121.
Zuckerman
M
. The sensation seeking scale V (SSS-V): still reliable and valid
. Pers Individ Differ
. 2007
;43
(5
):1303
–5
. .122.
Patton
JH
, Stanford
MS
, Barrat
ES
. Factor structure of the Barrat impulsiveness scale
. J Clin Psychol
. 1995
;51
:768
–74
. .123.
Eysenck
SB
, Eysenck
HJ
. Impulsiveness and venturesomeness: their position in a dimensional system of personality description
. Psychol Rep
. 1978
;43
(3 Pt 2
):1247
–55
. .124.
Schalling
D
, Åsberg
M
, Edman
G
, Oreland
L
. Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity
. Acta Psychiatr Scand
. 1987
;76
(2
):172
–82
. .125.
af Klinteberg
B
, Oreland
L
. Hyperactive and aggressive behaviors in childhood as related to low platelet monoamine oxidase (MAO) activity at adult age: a longitudinal study of male subjects
. Pers Individ Differ
. 1995
;19
(3
):373
–83
. .126.
Netter
PS
, Reuter
M
. Size and time of hormone responses to serotonergic and noradrenergic challenge tests as related to facets of depression
. Pharmacopsychiatry
. 2005
;38
(05
):A171
. .127.
Kuikka
JT
, Tiihonen
J
, Bergström
KA
, Karhu
J
, Räsänen
P
, Eronen
M
. Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis
. Neurosci Lett
. 1998
;253
(3
):195
–7
. .128.
Pine
A
, Shiner
T
, Seymour
B
, Dolan
RJ
. Dopamine, time, and impulsivity in humans
. J Neurosci
. 2010
;30
(26
):8888
–96
. .129.
Nutt
DJ
, Lingford-Hughes
A
, Erritzoe
D
, Stokes
PR
. The dopamine theory of addiction: 40 years of highs and lows
. Nat Rev Neurosci
. 2015
;16
(5
):305
–12
. .130.
Gerra
G
, Zaimovic
A
, Timpano
M
, Zambelli
U
, Delsignore
R
, Brambilla
F
. Neuroendocrine correlates of temperamental traits in humans
. Psychoneuroendocrinology
. 2000
;25
(5
):479
–96
. .131.
D’Amour-Horvat
V
, Leyton
M
. Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects
. Front Behav Neurosci
. 2014
;8
:432
.132.
Eagle
DM
, Robbins
TW
. Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine
. Behav Neurosci
. 2003
;117
(6
):1302
. .133.
Winstanley
CA
, Eagle
DM
, Robbins
TW
. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies
. Clin Psychol Review
. 2006
;26
(4
):379
–95
. .134.
Mar
AC
, Walker
AL
, Theobald
DE
, Eagle
DM
, Robbins
TW
. Dissociable effects of lesions to orbitofrontal cortex subregions on impulsive choice in the rat
. J Neurosci
. 2011
;31
(17
):6398
–404
. .135.
Zuckerman
M
. Sensation seeking, risk taking, and health. In: Janisse MP, editor: Individual differences, stress, and health psychology
. Contributions to Psychology and Medicine. Springer: New York;
1988
.72
–88
. .136.
Ballenger
JC
, Post
RM
, Jimerson
DC
, Lake
CR
, Murphy
D
, Zuckerman
M
, et al. Biochemical correlates of personality traits in normals: an exploratory study
. Pers Individ Differ
. 1983
;4
(6
):615
–25
. .137.
Zuckerman
M
, Ballenger
JC
, Jimerson
DC
, Murphy
DL
, Post
RM
. A correlational test in humans of the biological models of sensation seeking, impulsivity, and anxiety
. Biological basis of sensation seeking, impulsivity, and anxiety
. Hillside, NJ
: Erlbaum
; 1983
. p. 229
–48
.138.
Zuckerman
M
. P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates
. Neuropsychobiology
. 1993
;28
(1–2
):30
–6
. .139.
Levy
F
. Pharmacological and therapeutic directions in ADHD: specificity in the PFC
. Behav Brain Funct
. 2008
;4
(1
):1
–9
. .140.
Heil
SH
, Holmes
HW
, Bickel
WK
, Higgins
ST
, Badger
GJ
, Laws
HF
, et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users
. Drug Alcohol Depend
. 2002
;67
(2
):149
–15
. .141.
Robinson
ES
, Eagle
DM
, Mar
AC
, Bari
A
, Banerjee
G
, Jiang
X
, et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat
. Neuropsychopharmacology
. 2008
;33
(5
):1028
–37
. .142.
Del Campo
N
, Chamberlain
SR
, Sahakian
BJ
, Robbins
TW
. The roles of dopamine and noradrenaline in the pathophysiology and treatment of s-deficit/hyperactivity disorder
. Biol Psychiatry
. 2011
;69
(12
):e145
–57
. .143.
Bari
A
, Robbins
TW
. Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task
. Psychopharmacology
. 2013
;230
(1
):89
–111
. .144.
Sasamori
H
, Ohmura
Y
, Yoshida
T
, Yoshioka
M
. Noradrenaline reuptake inhibition increases control of impulsive action by activating D1-like receptors in the infralimbic cortex
. Eur J Pharmacol
. 2019
;844
:17
–25
. .145.
Netter
P
, Reuter
M
, Toll
C
, Hennig
J
. Impulsivity and impulse control: relations to neurotransmitter responsivityBrain storming session at the Congress of the College of Neuropsychopharmacology
. Paris
: CINP
; 2004
.146.
Wilens
TE
. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder
. J Clin Psychopharmacol
. 2008
;28
(3
):S46
–53
. .147.
Lachner
G
, Wittchen
HU
, Perkonigg
A
, Holly
A
, Schuster
P
, Wunderlich
, et al. Structure, content and reliability of the Munich-Composite International Diagnostic Interview (M-CIDI) substance use sections
. Eur Addict Res
. 1998
;4
(1–2
):28
–41
. .148.
Carver
CS
, White
TL
. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales
. J Pers Soc Psychol
. 1994
;67
(2
):319
. .149.
Lejoyeux
M
, Arbaretaz
M
, McLoughlin
M
, Adès
J
. Impulse control disorders and depression
. J Nerv Ment Dis
. 2002
;190
(5
):310
–4
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
